07:00 , Mar 24, 2014 |  BioCentury  |  Emerging Company Profile

Bullet: Idiotype builder

Bullet Biotechnology Inc. is using new sequencing and manufacturing methods to develop an idiotype cancer vaccine that it anticipates will be more effective than first-generation products. President and CEO Willie Quinn said the first wave...
08:00 , Nov 6, 1995 |  BC Week In Review  |  Company News

Biomira, OncoTherapeutics Inc. deal

BIOMF completed its previously announced acquisition of privately held OncoTherapeutics (Cranbury, N.J.), for 3 million common shares of BIOMF (see BioCentury Sept. 5). OncoTherapeutics is developing cancer therapies using liposomal technologies and applied immunology. BIOMF,...
07:00 , Sep 5, 1995 |  BC Week In Review  |  Company News

Biomira, OncoTherapeutics Inc. deal

BIOMF (Edmonton, Alberta) reached an agreement in principle to acquire OncoTherapeutics, a developer of cancer therapies using liposomal technologies and applied immunology, for 3 million common shares. BIOMF, which closed at $4 on Friday, has...